PIASxalpha differentially regulates the amplitudes of transcriptional responses following activation of the ERK and p38 MAPK pathways.

Activation of the MAP kinase pathways leads to changes in gene expression profiles through direct targeting of transcription factors and their coregulators. Here we identify PIASxalpha as a key regulator that determines the differential response of the transcription factor Elk-1 to the ERK and the stress-activated p38 MAP kinase pathways. While PIASxalpha functions as a coactivator to facilitate SUMO and HDAC-2 removal from Elk-1 in response to ERK pathway activation, PIASxalpha acts in the opposite manner to inhibit HDAC-2 and SUMO loss following stress-activated MAP kinase pathway signaling. Thus, PIASxalpha either enhances or dampens down the activation of Elk-1 target genes, depending on the pathway activated. p38 MAP kinase-mediated PIASxalpha phosphorylation allows it to switch between these two alternative modes of operation. Thus, PIASxalpha acts as a key signal integrator that permits different responses from the same transcription factor, depending on the signaling pathway that is activated.

[1]  P. Cohen,et al.  The specificities of protein kinase inhibitors: an update. , 2003, The Biochemical journal.

[2]  K. Shuai,et al.  Regulation of gene-activation pathways by PIAS proteins in the immune system , 2005, Nature Reviews Immunology.

[3]  A. Shevchenko,et al.  Transcription Control by E1A and MAP Kinase Pathway via Sur2 Mediator Subunit , 2002, Science.

[4]  A. Sharrocks,et al.  SUMO promotes HDAC-mediated transcriptional repression. , 2004, Molecular cell.

[5]  A. Yen,et al.  Regulation of MCL1 through a Serum Response Factor/Elk-1-mediated Mechanism Links Expression of a Viability-promoting Member of the BCL2 Family to the Induction of Hematopoietic Cell Differentiation* , 1999, The Journal of Biological Chemistry.

[6]  S. Müller,et al.  Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[7]  C. Marshall,et al.  Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation , 1995, Cell.

[8]  Michael E. Greenberg,et al.  Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis , 1995, Science.

[9]  M. Karin,et al.  Mammalian MAP kinase signalling cascades , 2001, Nature.

[10]  A. Sharrocks Complexities in ETS-domain transcription factor function and regulation: lessons from the TCF (ternary complex factor) subfamily. The Colworth Medal Lecture. , 2001, Biochemical Society transactions.

[11]  F. Sladek,et al.  MAP kinase phosphorylation‐dependent activation of Elk‐1 leads to activation of the co‐activator p300 , 2003, The EMBO journal.

[12]  J. Blenis,et al.  ERK and p38 MAPK-Activated Protein Kinases: a Family of Protein Kinases with Diverse Biological Functions , 2004, Microbiology and Molecular Biology Reviews.

[13]  Andrew D Sharrocks,et al.  Transcriptional regulation by the MAP kinase signaling cascades. , 2003, Gene.

[14]  Juliana Xu,et al.  Activation of p53 by Protein Inhibitor of Activated Stat1 (PIAS1)* , 2002, The Journal of Biological Chemistry.

[15]  T. Ohshima,et al.  Transforming Growth Factor-β-mediated Signaling via the p38 MAP Kinase Pathway Activates Smad-dependent Transcription through SUMO-1 Modification of Smad4* , 2003, Journal of Biological Chemistry.

[16]  E. Kremmer,et al.  PIASy-Deficient Mice Display Modest Defects in IFN and Wnt Signaling1 , 2004, The Journal of Immunology.

[17]  Andrew D Sharrocks Complexities in ETS-domain transcription factor function and regulation: lessons from the TCF (ternary complex factor) subfamily. The Colworth Medal Lecture. , 2002, Biochemical Society transactions.

[18]  R. Hipskind,et al.  SUMOylation regulates nucleo-cytoplasmic shuttling of Elk-1 , 2004, The Journal of cell biology.

[19]  J. Saxton,et al.  Ternary complex factors: prime nuclear targets for mitogen-activated protein kinases. , 2003, The international journal of biochemistry & cell biology.

[20]  L. Mahadevan,et al.  MAP kinases as structural adaptors and enzymatic activators in transcription complexes , 2004, Journal of Cell Science.

[21]  Andrew D Sharrocks,et al.  Dynamic interplay of the SUMO and ERK pathways in regulating Elk-1 transcriptional activity. , 2003, Molecular cell.

[22]  A. Sharrocks,et al.  The Elk-1 ETS-Domain Transcription Factor Contains a Mitogen-Activated Protein Kinase Targeting Motif , 1998, Molecular and Cellular Biology.

[23]  J. Avruch,et al.  Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. , 2001, Physiological reviews.

[24]  A. Sharrocks,et al.  PIASx acts as an Elk‐1 coactivator by facilitating derepression , 2005, The EMBO journal.

[25]  A. Sharrocks,et al.  Ternary Complex Factor-Serum Response Factor Complex-Regulated Gene Activity Is Required for Cellular Proliferation and Inhibition of Apoptotic Cell Death , 2004, Molecular and Cellular Biology.

[26]  H. Yasuda,et al.  Involvement of PIAS1 in the sumoylation of tumor suppressor p53. , 2001, Molecular cell.

[27]  Karen E Gascoigne,et al.  The ETS Domain Transcription Factor Elk-1 Regulates the Expression of Its Partner Protein, SRF* , 2005, Journal of Biological Chemistry.

[28]  B. Wasylyk,et al.  Ets ternary complex transcription factors. , 2004, Gene.

[29]  L. Bruhn,et al.  PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. , 2001, Genes & development.

[30]  S. Müller,et al.  PIAS/SUMO: new partners in transcriptional regulation , 2003, Cellular and Molecular Life Sciences CMLS.

[31]  O. Jänne,et al.  PIAS Proteins Modulate Transcription Factors by Functioning as SUMO-1 Ligases , 2002, Molecular and Cellular Biology.

[32]  A. Sharrocks,et al.  Convergence of the SUMO and MAPK pathways on the ETS-domain transcription factor Elk-1. , 2006, Biochemical Society symposium.